Events Search and Views Navigation
November 2019
Noble Life Sciences is Exhibiting at ACT 2019, 40th Annual Meeting. Noble Life Sciences is a preclinical CRO providing GLP Safety Toxicology Testing Services using small to large animal models to support small molecule, biologic, and cell and gene therapy products. Visit us at Booth # 503 to discuss your safety toxicology testing needs. Schedule a meeting to learn how Noble can help in moving forward your toxicology program at an accelerated pace. Stay tuned, we will be updating this page with more information as we get closer to the meeting.
Find out moreFebruary 2020
Visit us at Booth #31 IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
Find out moreMarch 2020
Noble Life Sciences is Exhibiting at SOT 2020, 59th Annual Meeting. Noble Life Sciences is a preclinical CRO providing GLP Safety Toxicology Testing Services using small to large animal models to support small molecule, biologic, and cell and gene therapy products. Visit us at Booth # 213 to discuss your safety toxicology testing needs. Schedule a meeting to learn how Noble can help in moving forward your toxicology program at an accelerated pace.
Find out moreApril 2020
R&D + Strategic Partnering For The Global Vaccine Industry Visit us at Booth #1
Find out moreMay 2020
The Symposium on Advanced Wound Care Spring | Wound Healing Society (SAWC Spring | WHS) meeting features exciting new cutting-edge topics led by the most dynamic and influential educators in wound healing. Be a part of the movement and join your global community of difference makers at SAWC who are committed to providing better care and better outcomes. Visit us at Booth #105
Find out moreThe 41st Annual Meeting will include a wide-ranging scientific program, a welcome reception, the popular poster session reception, an awards ceremony and luncheon, distinguished plenary speakers, and numerous professional networking events.
Find out moreSeptember 2020
World Vaccine Congress Washington, the world's most exciting vaccine event is coming to you virtually. Noble Life Sciences is exhibiting at World Vaccine Congress Washington 2020, September 28 – October 1, 2020. Noble Life Sciences is a preclinical CRO validated portfolio of preclinical in vitro assays and in vivo disease models in infectious diseases and immunology to support preclinical development. Connect with us to discuss your preclinical vaccine development needs. Schedule a meeting to learn how Noble can support to accelerate and de-risk your vaccine development.
Find out moreOctober 2020
Noble Life Sciences in partnership with NorthEast BioLab is hosting a webinar. Overview: The need for expedited drug development and efficient capital allocation has placed a justified emphasis on early in vivo testing for pharmacology and disease modulation. In this webinar, we would share actionable insights from our 100+ years of collective experience managing drug discovery, pharmacokinetics (PK), and biomarker testing studies. Agenda: Drug discovery screening process from target selectivity to potency in preclinical disease models In vivo proof-of-concept PK and Biomarker testing towards clinical efficacy based on drug exposure and biological response In vitro ADME (protein binding, [...]
Find out moreDecember 2020
Noble Life Sciences Hosts Panel Discussion “Vaccinology in the 21st Century: Engineering an Effective Vaccine Platform” Featuring: Andrew Lees, PhD, Scientific Director, Fina BioSolutions Peter Pushko, PhD, Chief Scientific Officer, Medigen Spencer Stonier, PhD, Director Vaccines Pipeline, Emergent BioSolutions Todd Parsley, PhD, Director Infectious Diseases, Noble Life Sciences (Moderator) Register Now Background: With much of the world’s focus on the development of SARS-CoV-2 vaccine, we are bringing an expert panel together to discuss the challenges and strategies for engineering an effective and safe vaccine. The panelists will share their expertise in vaccine development to discuss topically relevant aspects of [...]
Find out moreFebruary 2021
Noble Life Sciences Hosts Webinar “Live animal imaging in Oncology preclinical drug development” Speaker: Dr. Stephen Horrigan, Chief Scientific Officer, Noble Life Sciences Register Now Small animal optical imaging provides oncology researchers the ability to perform non-invasive longitudinal monitoring of disease progression, detection of metastasis and micro metastasis, and to accurately quantify tumor burden in a wide variety of animal models. This can be used to effectively monitor and quantitate responses to therapeutics and develop translational biomarkers that can be used throughout your drug development program. The sensitivity, versatility and non-invasive nature of combined luminescent and fluorescent imaging also [...]
Find out more